Literature DB >> 27144804

Physical Activity Level of Post-menopausal Women with Low Bone Mineral Density.

Glauber Dallanezi1, Beatriz Funayama Alvarenga Freire2, Eliana Aguiar Petri Nahás3, Jorge Nahás-Neto3, José Eduardo Corrente4, Gláucia Maria Ferreira da Silva Mazeto2.   

Abstract

Introduction Proper physical activity is related to the prevention and the treatment of osteoporosis. Purpose To assess the level of physical activity (PA) in post-menopausal women with low bone mineral density (BMD). Methods This cross-sectional clinical study included 123 post-menopausal women. The inclusion criteria were: age of ≥ 45 years with last menses at least 12 months prior to the initiation of the study, and bone density scan (BDS) values measured over the preceding 12 months. Women with severe osteoarthritis were excluded. Women were allocated into three groups, according to BMD measured by BDS [osteoporosis (OP; 54 women), osteopenia (35 women), and normal bone density (NBD; 35 women)], and compared for general, clinical, and anthropometric data, and for PA level. The latter was assessed using the International Physical Activity Questionnaire (IPAQ), in metabolic equivalent of task (MET) units. Participants were classified as sedentary, active or very active. Quantitative variables were compared using ANOVA followed by Tukey's test. Associations between qualitative variables were tested by Chi-square (χ2) or Fisher's exact test. In order to check for differences among groups and IPAQ domains, a generalized linear model with Gamma distribution was adjusted for values in METs. Results The OP group differed from the NBD group regarding age (61.8 ± 10.1 and 52.9 ± 5.4 years), percentage of participants with self-declared white ethnicity (43.9 and 28.0%), body mass index (BMI - 25.7 ± 5.4 and 30.9 ± 5.1 kg/m(2)), and time since menopause (15.5 ± 7.5 and 5.8 ± 4.5 years). Smoking rates were higher in the OP (55.6%) and NBD groups (33.3%) than in the osteopenia group (11.1%). Within the OP group, the rate of subjects with sedentary lifestyles was higher (42.6%), and time spent sitting was greater (344.3 ± 204.8 METs) than in the groups with osteopenia (20.0% and 300.9 ± 230.6 METs) and NBD (17.7% and 303.2 ± 187.9 METs). Conclusions The rate of sedentary lifestyles was higher in post-menopausal women with OP than in those with either osteopenia or NBD. In order to change this physical inactivity profile, strategies should be created to address this group of patients. Thieme Publicações Ltda Rio de Janeiro, Brazil.

Entities:  

Mesh:

Year:  2016        PMID: 27144804     DOI: 10.1055/s-0036-1583757

Source DB:  PubMed          Journal:  Rev Bras Ginecol Obstet        ISSN: 0100-7203


  4 in total

1.  Physical activity and hypocaloric diet recovers osteoblasts homeostasis in women affected by abdominal obesity.

Authors:  Viviana M Bimonte; Simona Fittipaldi; Chiara Marocco; Gian Pietro Emerenziani; Rachele Fornari; Laura Guidetti; Eleonora Poggiogalle; Emanuele Nicolai; Luigi Di Luigi; Lorenzo M Donini; Carlo Baldari; Andrea Lenzi; Emanuela A Greco; Silvia Migliaccio
Journal:  Endocrine       Date:  2016-12-16       Impact factor: 3.633

2.  WHOLE BODY AND REGIONAL BONE MINERAL CONTENT AND DENSITY IN WOMEN AGED 20-75 YEARS.

Authors:  M A Boyanov
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Apr-Jun       Impact factor: 0.877

3.  Soy protein improves tibial whole-bone and tissue-level biomechanical properties in ovariectomized and ovary-intact, low-fit female rats.

Authors:  Pamela S Hinton; Laura C Ortinau; Rebecca K Dirkes; Emily L Shaw; Matthew W Richard; Terese Z Zidon; Steven L Britton; Lauren G Koch; Victoria J Vieira-Potter
Journal:  Bone Rep       Date:  2018-05-18

4.  Prevalence of osteoporosis among the elderly population of Iran.

Authors:  Noushin Fahimfar; Sima Noorali; Shakiba Yousefi; Safoora Gharibzadeh; Gita Shafiee; Nekoo Panahi; Mahnaz Sanjari; Ramin Heshmat; Farshad Sharifi; Neda Mehrdad; Alireza Raeisi; Iraj Nabipour; Bagher Larijani; Afshin Ostovar
Journal:  Arch Osteoporos       Date:  2021-01-21       Impact factor: 2.617

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.